36
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Pathological Roles of Interleukin-15 in Adult T-cell Leukemia

&
Pages 37-45 | Accepted 18 Jan 1999, Published online: 01 Jul 2009
 

Abstract

Interleukin-15 (IL-15) is a 14-kDa glycoprotein belonging to the same four helix bun-dle-cytokine family as IL-2. Although the biological activity of L-15 in vitro has been studied extensively. its physiological role is still obscure. The receptors for IL-15 and IL-2 consist of three subunits, an unique α chain and shared β and γ chains. Since β and γ chains transduce the signals from the receptors, both cytokines share similar biologic functions, although IL-15 and IL-2 do not have sequence homology. The α chains function to increase binding affinity for each cytokines. Adult T-cell leukemia (ATL) cells constitutively express the IL-2 receptor (IL-2R) a and expression is believed to be essential in the early stages of disease development. We have recently shown that ATL cells also express the complete form of IL-15R including the α chain, and that ATL cells proliferate in response to exogenous IL-15. Since the mRNA of IL-15 is ubiquitous and is detected in many tissues and cells, it is possible that IL-15R stimulation is involved in the development and progression of An. Here, we review recent studies on IL-15 and IL-15R and their association with ATL and other lymphoproliferative disorders.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.